Rankings
▼
Calendar
MRVI FY 2018 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
MRVI
Maravai LifeSciences Holdings, Inc.
$970M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$124M
Gross Profit
$63M
50.9% margin
Operating Income
$16M
13.3% margin
Net Income
-$18M
-14.3% margin
EPS (Diluted)
$-0.20
Cash Flow
Operating Cash Flow
-$186,000
Free Cash Flow
-$4M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$540M
Total Liabilities
$392M
Stockholders' Equity
$144M
Cash & Equivalents
$22M
← FY 2019
All Quarters
